Modified Nijmegen Bethesda Assay

Modified Nijmegen Bethesda Assay
Mar 17, 2018 1:27pm

On March 13, 2018. Precision BioLogic Inc., Dartmouth, NS, announced their development of a new approach to standardize and improve factor VIII inhibitor testing. Their press release (tap or click) referenced new data presented in a poster at the Thrombosis and Hemostasis Societies of North America, March 8–10, 2018 meeting, in San Diego, CA, USA. More information is also available on the Precision BioLogic Inc. web site publications list.


Leave A Comment

You must be logged in to Comment - Sign In